Please note - a separate email address is required for each medical professional attending the program.
PHA Pediatric Preceptorship Program:
A Collaborative Approach for Pediatric Clinicians on the Front Line
Monroe Carell Jr. Children's Hospital at Vanderbilt
VCH Boardroom, 2nd Floor
2200 Children's Way
Nashville, Tennesssee
9:00 - 9:30 AM
Registration
9:30 AM - Noon
Diagnosis and Classification of Pulmonary Hypertension in Children
Benjamin Frank, MD
Genetics and the Role of Genetic Testing in Pediatric Pulmonary Hypertension
Eric D. Austin, MD, MSCI
A Comprehensive Approach to Caring for the Child With Pulmonary Hypertension
D. Dunbar Ivy, MD
Noon - 1:00 PM
Lunch
1:00 - 3:30 PM
Premature-Associated Lung Disease and Pediatric Pulmonary Hypertension
Eric D. Austin, MD, MSCI
Pulmonary Arterial Hypertension Associated With Congenital Heart Disease
Benjamin Frank, MD
Case Presentations and Discussion
Anna M. Brown, DNP, APRN, CPNP, George T. Nicholson, MD, and Michael G. O'Connor, MD, with Eric D. Austin, MD, MSCI, Moderating
Preceptorship Faculty
From Monroe Carell Jr. Children's Hospital at Vanderbilt & Vanderbilt University School of Medicine
Eric D. Austin, MD, MSCI, Moderator
Associate Professor of Pediatrics
Division of Allergy, Immunology, and Pulmonary Medicine
Director, Vanderbilt Pediatric Pulmonary Hypertension Program
Anna M. Brown, DNP, APRN, CPNP
Assistant Professor, School of Nursing
Division of Allergy, Immunology, and Pulmonary Medicine
Nurse Practitioner, Vanderbilt Pediatric Pulmonary Hypertension Program
George T. Nicholson, MD
Assistant Professor of Pediatrics
Division of Cardiology
Michael G. O'Connor, MD
Assistant Professor of Pediatrics
Division of Allergy, Immunology, and Pulmonary Medicine
From The Heart Institute, Children's Hospital Colorado & University of Colorado School of Medicine
D. Dunbar Ivy, MD
Selby's Chair in Pediatric Cardiology
Professor of Pediatrics
Director, Pulmonary Hypertension Program
Benjamin Frank, MD
Assistant Professor of Pediatrics
Division of Pediatric Cardiology
A complimentary lunch will be served.
To comply with the Sunshine Act, when a meal is provided, physicians will be asked for their National Provider Identification (NPI) and state license number at registration.
Target Audience
This activity has been designed for pediatrics pulmonologists, cardiologists, and rheumatologists, and general pediatricians, as well as nurses, physician assistants, and other allied health professionals who help care for children with pulmonary arterial hypertension.
Educational Objectives
The PHA Pediatric Preceptorship Program is designed to improve competence, performance, and pediatric patient care practices by instructing front-line clinicians in the highest quality of case for children with PAH by combining didactic discourse and highly interactive case-based discussion. At the conclusion of this program, participants should be able to:
- Define key pathophysiologic and epidemiologic components of PAH
- Accurately diagnose pediatric patients through comprehensive screening and early recognition of symptoms
- Evaluate the child's condition and prescribe optimal long-term management, including knowing when and how to treat and when to consult with colleagues at an established PAH center
- Tailor comprehensive care for complex pediatric patient populations
|
Accreditation In support of improving patient care, this activity has been planned and implemented by Washington University School of Medicine in St. Louis, Continuing Medical Education and the Pulmonary Hypertension Association. Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
|
|
Credit Awarded for This Activity Washington University School of Medicine in St. Louis designates this live activity for a maximum of 5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
|
Disclosure Statement
It is the policy of Washington University School of Medicine in St. Louis, Continuing Medical Education, that planners, faculty and other persons who may influence content of this CME activity disclose all relevant financial relationships with commercial interests in order for CME staff to identify and resolve any potential conflicts of interest prior to the educational activity. Faculty must also disclose any planned discussion of unlabled/unapproved uses of drugs or devices during their presentation. Detailed disclosures will be made in activity handout materials.
Preceptorship Medical Education Program Committee Members
Jean M. Elwing, MD, FCCP (Committee Chair), University of Cincinnati College of Medicine; Eric D. Austin, MD, MSCI, Vanderbilt University School of Medicine; Christopher F. Barnett, MD, MPH, MedStar Washington Hospital Center; Kelly Chin, MD, MSCS, University of Texas Southwestern Medical Center; Lorinda Chung, MD, MS, Stanford University School of Medicine; Gustavo A. Heresi, MD, MS, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; Richard A. Krasuski, MD, FACC, FAHA, FESC, Duke University School of Medicine; Tim Lahm, MD, Indiana University School of Medicine; Vallerie V. McLaughlin, MD, FACC, FAHA, FCCP (Advisor), Michigan Medicine
Washington University School of Medicine in St. Louis, CME Reviewers
Murali M. Chakinala, MD, FCCP — Content
Allyson R. Zazulia, MD — CME
This activity is supported by educational grants from:
Diamond Level Actelion Pharmaceuticals US, Inc.
|
Gold Level United Therapeutics Corporation
|